APA (7th ed.) Citation

TS, L., J, W., J, H., S, C., Y, H., B, Z., . . . YC, L. (2026). Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation. Pharmaceutics, 18(3), . https://doi.org/10.3390/pharmaceutics18030324

Chicago Style (17th ed.) Citation

TS, Lin, et al. "Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation." Pharmaceutics 18, no. 3 (2026). https://doi.org/10.3390/pharmaceutics18030324.

MLA (9th ed.) Citation

TS, Lin, et al. "Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation." Pharmaceutics, vol. 18, no. 3, 2026, https://doi.org/10.3390/pharmaceutics18030324.